Novartis Sells Eye Drugs to Bausch for Up to $2.5 Billion
Novartis AG agreed to sell part of its portfolio of eye medicines to Bausch + Lomb Corp. in
2023-06-30 20:53
Last Taboo for Hit Obesity Drug Is Asking When to Stop
Two years and more than a million prescriptions after Wegovy first went on sale, there’s one taboo question
2023-06-30 12:18
US FDA Uncovers Fresh Faults at India’s Second-Biggest Drugmaker
US Food and Drug Administration officials found multiple faults at a plant run by one of India’s biggest
2023-06-30 05:27
Monster Close to Buying Rival Bang Energy For $362 Million
Monster Beverage Corp. is closing in on a $362 million deal to acquire rival drink maker Bang Energy
2023-06-30 03:51
Ex-Pfizer Employee Charged With Illegal Trades on Paxlovid Trial
A former Pfizer Inc. employee was charged with using inside information about the company’s Covid-19 treatment Paxlovid to
2023-06-30 02:16
Dealmakers Adrift as $1 Trillion Vanishes in First-Half
The world’s dealmakers are roughly $1 trillion down in one of the worst years for takeovers and stock
2023-06-29 16:52
Ipsen Gets FDA Advisers’ Backing for Rare Bone Disease Drug
Ipsen SA’s drug for a rare bone disease got support from a panel of US drug regulatory advisers,
2023-06-29 15:17
BlackRock, Schroders Hunt China Deals in Growing Private Markets
Global fund managers building out private markets activities in China are finding lucrative opportunities to deploy capital even
2023-06-29 13:55
Pfizer’s Exit Halves Japan Biotech Firm Value In Just Three Days
Sosei Group Corp. has lost over half of its market value in just three days on concern about
2023-06-29 11:56
Irish GDP Growth to Stall as Pharma Exports Weaken, ESRI Says
Ireland’s economy will grow at a slower pace than previously thought in 2023 due to weakening exports and
2023-06-29 07:29
Rise of Vocal Investors in Japan Is Fueling Hunt for IR Talent
Japanese businesses facing greater scrutiny from shareholders and regulators are competing for investor-relations talent, turning to investment funds,
2023-06-29 05:26
Catalent Is Linked to Regeneron’s Eye-Drug Rejection in Latest Misstep
Problems at a Catalent Inc. production facility led US regulators to deny a key drug application from Regeneron
2023-06-29 00:21